<DOC>
	<DOCNO>NCT00086749</DOCNO>
	<brief_summary>RATIONALE : High estrogen level may associate dense breast tissue increase risk develop breast cancer . Tamoxifen may effective reduce breast density decrease estrogen level . PURPOSE : This phase I trial study well tamoxifen work reduce breast density premenopausal woman breast cancer high risk develop breast cancer .</brief_summary>
	<brief_title>Effect Tamoxifen Breast Density Premenopausal Women With Breast Cancer High Risk Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine whether breast density , measure digital mammography , decrease premenopausal woman receive tamoxifen breast cancer breast cancer risk reduction . - Determine whether breast density , determine trained mammographer , decrease patient treated drug . - Correlate tamoxifen-induced symptom estrogen target tissue change salivary steroid patient treated drug . Secondary - Determine effect drug salivary steroid regularly cycle amenorrheic patient . - Correlate change breast density tamoxifen-induced alteration sex steroid level , measure saliva , patient treat drug . OUTLINE : Patients receive oral tamoxifen daily . Treatment continue 5 year absence disease metastasis ( patient know breast cancer ) diagnosis breast cancer ( patient undergo risk reduction ) . Patients undergo mammography determine breast density baseline , 6 12 month , annually 4 year . Patients also collect daily salivary sample 30-day period surround image study measure salivary estradiol progesterone level . The result salivary hormone study correlate density change study completion . PROJECTED ACCRUAL : A total 100 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Initiating tamoxifen sole systemic treatment breast cancer OR breast cancer risk reduction Undergoing mammography least annually No bilateral breast cancer stage IV breast cancer Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age 20 45 Sex Female Menopausal status Premenopausal No change menstrual pattern within past 6 month Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Not pregnant nursing No plan pregnancy within next 5 year No medical psychiatric disorder would preclude give informed consent PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy breast cancer Endocrine therapy See Disease Characteristics No prior tamoxifen 1 month duration Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
</DOC>